Copyright
©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1020-1030
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1020
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1020
Table 1 Baseline characteristics, n (%)
| Overall | 5-year survivor | Non-5-year survivor | P value | |
| Median age (IQR) | 62 (56-69) | 57 (51.25-63.75) | 62 (56-70) | < 0.01 |
| Sex (%Male) | 348 (70.0) | 36 (78.3) | 312 (69.2) | 0.27 |
| Race | 0.23 | |||
| Whites | 276 (55.5) | 23 (50.0) | 253 (56.1) | |
| Blacks | 53 (10.7) | 2 (4.3) | 51 (11.3) | |
| Hispanics | 77 (15.5) | 8 (17.4) | 69 (15.3) | |
| API | 84 (16.9) | 13 (28.3) | 71 (15.7) | |
| Others | 7 (1.4) | 0 (0) | 7 (1.6) | |
| AJCC stages | < 0.01 | |||
| I | 116 (23.3) | 19 (41.3) | 97 (21.5) | |
| II | 90 (18.1) | 19 (41.3) | 71 (15.7) | |
| III | 78 (15.7) | 5 (10.9) | 73 (16.2) | |
| IV | 139 (28.0) | 1 (2.2) | 138 (30.6) | |
| Unknown | 74 (14.9) | 2 (4.3) | 72 (16.0) | |
| Metastasis | 128 (25.8) | 1 (2.2) | 127 (28.2) | < 0.01 |
| Tumor size < 50 mm | 177 (35.6) | 34 (91.9) | 143 (56.5) | < 0.01 |
| Treatment | ||||
| LRT | 24 (4.8) | 2 (4.3) | 22 (4.9) | 1.00 |
| Resection | 119 (23.9) | 21 (45.7) | 98 (21.8) | < 0.01 |
| Transplant | 50 (10.6) | 20 (43.5) | 30 (6.7) | < 0.01 |
| Median survival months (IQR) | 6 (1-22) | 96.5 (83.25-129.5) | 5 (1-16) | < 0.01 |
- Citation: Sempokuya T, Wien EA, Pattison RJ, Ma J, Wong LL. Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma. World J Hepatol 2020; 12(11): 1020-1030
- URL: https://www.wjgnet.com/1948-5182/full/v12/i11/1020.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i11.1020